Short bowel condition Terminated Phase 1 / 2 Trials for Glucagon-like peptide II (DB12788)

Also known as: Short-bowel syndrome / Short Bowel Syndrome / Congenital volvulus

IndicationStatusPhase
DBCOND0020575 (Short bowel condition)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01573286Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal FailureTreatment